Patient and First-Degree Relatives Perceptions About Prediction and Prevention of Inflammatory Bowel Disease-A Multinational Survey

  • 0Division of Gastroenterology, Hospital Beatriz Ângelo, Loures, Portugal.

|

|

Summary

This summary is machine-generated.

Most individuals at risk of inflammatory bowel disease (IBD) are willing to undergo predictive testing and preventive interventions. Acceptance of minimally invasive tests and lifestyle changes is high, with some openness to medications.

Area Of Science

  • Gastroenterology and Immunology
  • Predictive Medicine
  • Public Health

Background

  • Identifying biomarkers for predicting inflammatory bowel disease (IBD) onset is advancing.
  • Little is known about the willingness of at-risk individuals for predictive testing and preventive interventions.

Purpose Of The Study

  • Assess acceptance of predictive tests and preventive interventions among individuals at risk of IBD.
  • Identify factors influencing decisions regarding IBD prediction and prevention.

Main Methods

  • An anonymized electronic survey was distributed to parents of children at risk of IBD and first-degree relatives (FDRs) of IBD patients.
  • The survey assessed acceptance of predictive tests, preventive interventions, and influencing variables.

Main Results

  • 85% of 1327 participants were willing to undergo predictive testing, preferring blood, stool, or saliva tests.
  • 98% accepted preventive interventions, favoring dietary changes, exercise, and probiotics.
  • Acceptance of immunosuppressive treatments varied based on efficacy, difficulty, and risks.

Conclusions

  • Most respondents prefer minimally invasive predictive tests and non-pharmacological preventive measures.
  • Over one-third would consider immunosuppressive medications to prevent IBD onset.
  • Disease knowledge and quality-of-life perceptions significantly influence preferences for IBD prediction and prevention strategies.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy 01:30

419

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

Assessment of the Gastrointestinal System II: Health Perception Pattern 01:29

162

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:

...

Inflammatory Bowel Disease I: Ulcerative Colitis 01:27

321

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

Inflammatory Bowel Disease II: Crohn's Disease 01:30

382

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

Inflammatory Bowel Disease IV: Pharmacological Management 01:29

189

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Chronic Bowel Disorders: Introduction 01:17

540

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...